|
2025
|
G/S
|
Adjuvants, other than for medical or veterinary purposes; biochemical catalysts; chemical prepara... |
|
2024
|
Invention
|
Heterocycle compounds as formyl peptide receptor modulators. Disclosed are compounds of formula (... |
|
|
Invention
|
Recombinant antibody, immunoconjugate comprising the same, and uses thereof in treating cancers. ... |
|
|
Invention
|
Anti-cd73 antibodies and use thereof.
The present invention relates to a novel antibody, an anti... |
|
2023
|
Invention
|
Fusion protein targeting pd-l1 and neutralizing gas6 and uses thereof.
The present disclosure re... |
|
|
Invention
|
Fusion protein targeting pd-l1 and neutralizing gas6 and uses thereof. The present disclosure rel... |
|
|
Invention
|
Chimeric antigen receptors, nucleic acids encod ing the same, and uses thereof in treating cancer... |
|
|
Invention
|
Chimeric antigen receptors, nucleic acids encoding the same, and uses thereof in treating cancers... |
|
|
Invention
|
Anti-human pd-l1 antibodies and their uses.
The present disclosure relates to an anti-PD-L1 anti... |
|
|
Invention
|
Anti-human pd-l1 antibodies and their uses. The present disclosure relates to an anti-PD-L1 antib... |
|
2022
|
Invention
|
Antibodies specific to transmembrane and coiled-coil domain family 3 and uses thereof. The presen... |
|
|
Invention
|
Compounds for mutant kras protein degradation and uses thereof. The present disclosure provides a... |
|
|
Invention
|
Anti-sense oligonucleotides and uses thereof.
Disclosed herein are novel single-stranded anti-se... |
|
|
Invention
|
Humanized anti-human neurotensin receptor 1 antibodies and their uses. A humanized anti-neurotens... |
|
|
Invention
|
Humanized anti-human neurotensin receptor 1 antibodies and their uses. The present disclosure rel... |
|
|
Invention
|
Anti-sense oligonucleotides and uses thereof. TXNDC5TXNDC5) mRNA. Also disclosed is use of the si... |
|
|
Invention
|
Anti-cd73 antibodies and use thereof. The present invention relates to a novel antibody, an antig... |
|
2021
|
Invention
|
Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof. The present dis... |
|
|
Invention
|
Compounds for mutant ras protein degradation. The present invention provides a compound of formul... |
|
2020
|
Invention
|
Heterocyclic pyrazole derivatives as type iii receptor tyrosine kinase inhibitors.
A compound, w... |
|
|
Invention
|
Heterocyclic pyrazole derivatives as type iii receptor tyrosine kinase inhibitors. A compound, wh... |
|
2019
|
Invention
|
Benzothiadiazine derivatives and compositions comprising the same for treating disorders mediated... |
|
|
Invention
|
Chimeric signal peptides for protein production. A chimeric signal peptide for protein expression... |
|
|
Invention
|
Anti-human csf-1r antibody and uses thereof. An antibody, or an antigen-binding fragment thereof,... |
|
|
Invention
|
Regioselective one-step process for synthesizing 2-hydroxyquinoxaline. A regioselective one-step ... |
|
|
Invention
|
Anti-human pd-l1 antibodies and their uses. An anti-PD-L1 antibody, or an antigen-binding fragmen... |
|
|
Invention
|
Humanized antibodies against human tim-3 and uses thereof. A humanized anti-human T-cell immunogl... |
|
|
Invention
|
Antibody protac conjugates.
An immunoconjugate having the Formula Ab-[L1-(A-L2-B)m]n, wherein: (... |
|
|
Invention
|
Antibody protac conjugates. An immunoconjugate having the Formula Ab-[L1-(A-L2mnn, wherein: (a) A... |
|
2018
|
Invention
|
In vitro diagnostic for prediction of drug efficacy. A 3D organoid is used for diagnosis or assay... |
|
|
Invention
|
Multiplex quantitative method for microrna. |
|
|
Invention
|
A method for predicting drug efficacy. A method for predicting therapeutic efficacy of a drug inc... |
|
|
Invention
|
Heterocycle compounds as tyro3, axl and mertk (tam) family of receptor tyrosine kinase inhibitors... |
|
|
Invention
|
Host cells with enhanced protein expression efficiency and uses thereof. A host cell for protein ... |
|
|
Invention
|
Humanized antibodies against globo h and uses thereof in cancer treatments. A humanized anti-Glob... |
|
|
Invention
|
Anti-cancer stemness drugs.
A compound for inhibiting BMI-1/MCL-1 having a structure of Formula ... |
|
|
Invention
|
Antibodies specific to alpha-enolase and uses thereof. An antibody, or an antigen-binding fragmen... |
|
2017
|
Invention
|
Klk6-mediated cns-specific antibody prodrug activation.
An antibody prodrug capable of being sel... |
|
|
Invention
|
A universal vaccine against influenza.
An antigenic short peptide includes 11 to 15 amino-acid r... |
|
|
Invention
|
Processes for preparing glycoprotein-drug conjugates. A process for modifying glycoproteins is pr... |
|
|
Invention
|
Peptides derived from kininogen-1 for protein drugs in vivo half-life extensions.
A recombinant ... |
|
|
Invention
|
Antibody-drug conjugates and uses thereof. An immunoconjugate, comprising an anti-EGFR antibody o... |
|
|
Invention
|
Hetroarylamine compounds for modulating the hedgehog pathway and preparing method and uses thereo... |
|
|
Invention
|
Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors. A compound, capable of inh... |
|
|
Invention
|
Modified antigen-binding fab fragments and antigen-binding molecules comprising the same.
The pr... |
